Sign inGet started

ANTX

AN2 Therapeutics, Inc.CIK 1880438 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
$23.2K
2 trades · 1 insiders
Open-mkt sales · 90d
$636.5K
18 trades · 2 insiders
Net · 90d
$-613.3K
Insiders on file
27

AI insights for ANTX PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for ANTX
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

$425.5K2026-08-17 buys — 2026-08-17 sales $425.5K08-172026-09-01 buys $23.2K 2026-09-01 sales $3.0K09-012026-09-03 buys — 2026-09-03 sales $74.1K09-032026-09-08 buys — 2026-09-08 sales $120.6K09-082026-09-09 buys — 2026-09-09 sales $13.3K09-09
■ Open-market buys (P)   ■ Open-market sales (S) · daily dollar value by transaction date

Insiders

InsiderRoleTradesBoughtSoldLast trade
Marks Gilbert LynnDirector19$0$02026-10-12
Martin Patricia A.Director19$0$02026-10-12
Aziz KabeerDirector, 10% Owner48$2.50M$3.98M2026-10-12
Trenor Cameron C. IIIChief Medical Officer4$0$02026-09-15
Readnour Robin ShaneDirector54$2.71M$745.1K2026-09-09
Williams Sarah JoannePrincipal Accounting Officer5$0$4.5K2026-09-01
FitzPatrick Margaret MDirector15$33.4K$02026-09-01
Zakrzewski Joseph SDirector21$27.9K$1.91M2026-08-14
Eizen Joshua MSee Remarks21$0$65.9K2026-07-08
Day LucyChief Financial Officer18$0$12.8K2026-03-19
Easom EricChief Executive Officer43$114.5K$1.55M2026-03-19
Chanda SanjayChief Development Officer18$0$13.3K2026-03-19
Wong StephanieDirector11$0$02026-03-19
Spigelman Melvin KDirector11$0$02026-03-19
Prior Stephen DavidChief Strategy Officer8$0$10.1K2026-01-06
Leonard Braden Michael10% Owner6$1.56M$3.09M2025-05-30
RA Capital Healthcare Fund LP10% Owner2$0$3.81M2024-08-09
Krause Kevin MichaelChief Strategy Officer13$0$201.3K2024-03-15
Eckburg PaulChief Medical Officer5$0$02024-03-15
Adjuvant Capital Management, LLC10% Owner4$0$1.99M2024-01-16
Adjuvant Global Health Technology Fund, L.P.10% Owner17$2.50M$1.71M2023-10-02
Adjuvant Global Health Technology Fund DE, L.P.10% Owner17$2.50M$265.2K2023-09-28
Adjuvant Capital GP, L.P.10% Owner2$0$6.4K2023-08-23
RA Capital Nexus Fund II, L.P.10% Owner5$16.83M$02023-08-18
Nazak Michael AdrianChief Accounting Officer2$0$02023-02-15
Shah Rajeev M.10% Owner3$16.7K$02022-08-04
Kolchinsky Peter10% Owner6$25.00M$02022-03-29

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Marks Gilbert LynnDirector A Award2026-10-122026-10-132,283— $084,156SEC↗
Martin Patricia A.Director A Award2026-10-122026-10-13389— $019,252SEC↗
Aziz KabeerDirector A Award2026-10-122026-10-132,465— $061,571SEC↗
Trenor Cameron C. IIIChief Medical Officer A Award deriv2026-09-152026-09-16233,333— $0233,333SEC↗
Trenor Cameron C. IIIChief Medical Officer A Award2026-09-152026-09-16116,667— $0116,667SEC↗
Trenor Cameron C. IIIChief Medical Officer A Award deriv2026-09-152026-09-16233,333— $0233,333SEC↗
Trenor Cameron C. IIIChief Medical Officer A Award2026-09-152026-09-16116,667— $0116,667SEC↗
Readnour Robin ShaneDirector S Sale2026-09-092026-09-11523$6.02 $3.1K557,467SEC↗
Readnour Robin ShaneDirector S Sale2026-09-092026-09-11585$6.02 $3.5K624,765SEC↗
Readnour Robin ShaneDirector S Sale2026-09-092026-09-11585$6.02 $3.5K624,765SEC↗
Readnour Robin ShaneDirector S Sale2026-09-092026-09-11523$6.02 $3.2K557,467SEC↗
Readnour Robin ShaneDirector S Sale2026-09-082026-09-085,294$6.02 $31.9K625,350SEC↗
Readnour Robin ShaneDirector S Sale2026-09-082026-09-084,725$6.02 $28.4K557,990SEC↗
Readnour Robin ShaneDirector S Sale2026-09-082026-09-085,294$6.02 $31.9K625,350SEC↗
Readnour Robin ShaneDirector S Sale2026-09-082026-09-084,725$6.02 $28.4K557,990SEC↗
Readnour Robin ShaneDirector S Sale2026-09-032026-09-083,223$6.07 $19.6K630,644SEC↗
Readnour Robin ShaneDirector S Sale2026-09-032026-09-082,877$6.07 $17.5K562,715SEC↗
Readnour Robin ShaneDirector S Sale2026-09-032026-09-083,223$6.07 $19.6K630,644SEC↗
Readnour Robin ShaneDirector S Sale2026-09-032026-09-082,877$6.07 $17.5K562,715SEC↗
FitzPatrick Margaret MDirector P Buy2026-09-012026-09-022,098$5.53 $11.6K10,708SEC↗
Williams Sarah JoannePrincipal Accounting Officer S Sale2026-09-012026-09-04272$5.53 $1.5K66,311SEC↗
FitzPatrick Margaret MDirector P Buy2026-09-012026-09-022,098$5.53 $11.6K10,708SEC↗
Williams Sarah JoannePrincipal Accounting Officer S Sale2026-09-012026-09-04272$5.53 $1.5K66,311SEC↗
Readnour Robin ShaneDirector S Sale2026-08-172026-08-1918,706$6.01 $112.4K633,867SEC↗
Readnour Robin ShaneDirector S Sale2026-08-172026-08-1916,696$6.01 $100.3K565,592SEC↗
Readnour Robin ShaneDirector S Sale2026-08-172026-08-1918,706$6.01 $112.4K633,867SEC↗
Readnour Robin ShaneDirector S Sale2026-08-172026-08-1916,696$6.01 $100.3K565,592SEC↗
Zakrzewski Joseph SDirector G Gift2026-08-142026-08-14405,880— $00SEC↗
Zakrzewski Joseph SDirector G Gift2026-08-142026-08-14405,880— $00SEC↗
Martin Patricia A.Director A Award2026-07-102026-07-10766— $018,863SEC↗
Marks Gilbert LynnDirector A Award2026-07-102026-07-102,789— $081,873SEC↗
Aziz KabeerDirector A Award2026-07-102026-07-102,852— $059,106SEC↗
Eizen Joshua MSee Remarks S Sale2026-07-082026-07-105,945$4.17 $24.8K206,554SEC↗
Williams Sarah JoannePrincipal Accounting Officer S Sale2026-05-292026-06-02265$4.43 $1.2K66,583SEC↗
Martin Patricia A.Director A Award2026-04-102026-04-101,192— $018,097SEC↗
Marks Gilbert LynnDirector A Award2026-04-102026-04-103,775— $079,084SEC↗
Aziz KabeerDirector A Award2026-04-102026-04-103,775— $056,254SEC↗
Easom EricChief Executive Officer A Award deriv2026-03-192026-03-23249,999— $0249,999SEC↗
Easom EricChief Executive Officer D To issuer deriv2026-03-192026-03-23267,650— $00SEC↗
Easom EricChief Executive Officer D To issuer deriv2026-03-192026-03-23249,999— $00SEC↗
Easom EricChief Executive Officer A Award deriv2026-03-192026-03-23225,000— $0225,000SEC↗
Easom EricChief Executive Officer D To issuer deriv2026-03-192026-03-23225,000— $00SEC↗
Easom EricChief Executive Officer A Award deriv2026-03-192026-03-23267,650— $0267,650SEC↗
Readnour Robin ShaneDirector A Award deriv2026-03-192026-03-2323,742— $023,742SEC↗
Readnour Robin ShaneDirector D To issuer deriv2026-03-192026-03-2320,724— $00SEC↗
Readnour Robin ShaneDirector A Award deriv2026-03-192026-03-2320,724— $020,724SEC↗
Readnour Robin ShaneDirector D To issuer deriv2026-03-192026-03-2323,742— $00SEC↗
Spigelman Melvin KDirector A Award deriv2026-03-192026-03-2316,941— $016,941SEC↗
Spigelman Melvin KDirector D To issuer deriv2026-03-192026-03-2316,941— $00SEC↗
Spigelman Melvin KDirector A Award deriv2026-03-192026-03-2310,362— $010,362SEC↗
Spigelman Melvin KDirector D To issuer deriv2026-03-192026-03-2310,362— $00SEC↗
Spigelman Melvin KDirector D To issuer deriv2026-03-192026-03-2323,742— $00SEC↗
Spigelman Melvin KDirector A Award deriv2026-03-192026-03-2323,742— $023,742SEC↗
Eizen Joshua MSee Remarks D To issuer deriv2026-03-192026-03-2350,150— $00SEC↗
Eizen Joshua MSee Remarks A Award deriv2026-03-192026-03-2350,150— $050,150SEC↗
Eizen Joshua MSee Remarks D To issuer deriv2026-03-192026-03-2392,000— $00SEC↗
Eizen Joshua MSee Remarks A Award deriv2026-03-192026-03-2392,000— $092,000SEC↗
Zakrzewski Joseph SDirector D To issuer deriv2026-03-192026-03-2399,999— $00SEC↗
Zakrzewski Joseph SDirector A Award deriv2026-03-192026-03-2310,362— $010,362SEC↗
Zakrzewski Joseph SDirector D To issuer deriv2026-03-192026-03-2310,362— $00SEC↗
Zakrzewski Joseph SDirector A Award deriv2026-03-192026-03-2323,742— $023,742SEC↗
Zakrzewski Joseph SDirector D To issuer deriv2026-03-192026-03-2323,742— $00SEC↗
Zakrzewski Joseph SDirector A Award deriv2026-03-192026-03-2399,999— $099,999SEC↗
Wong StephanieDirector D To issuer deriv2026-03-192026-03-2323,742— $00SEC↗
Wong StephanieDirector D To issuer deriv2026-03-192026-03-2310,362— $00SEC↗
Wong StephanieDirector A Award deriv2026-03-192026-03-2310,362— $010,362SEC↗
Wong StephanieDirector D To issuer deriv2026-03-192026-03-2324,999— $00SEC↗
Wong StephanieDirector A Award deriv2026-03-192026-03-2324,999— $024,999SEC↗
Wong StephanieDirector A Award deriv2026-03-192026-03-2323,742— $023,742SEC↗
FitzPatrick Margaret MDirector D To issuer deriv2026-03-192026-03-2323,742— $00SEC↗
FitzPatrick Margaret MDirector A Award deriv2026-03-192026-03-2323,742— $023,742SEC↗
FitzPatrick Margaret MDirector D To issuer deriv2026-03-192026-03-2310,362— $00SEC↗
FitzPatrick Margaret MDirector A Award deriv2026-03-192026-03-2310,362— $010,362SEC↗
FitzPatrick Margaret MDirector D To issuer deriv2026-03-192026-03-2311,463— $00SEC↗
FitzPatrick Margaret MDirector A Award deriv2026-03-192026-03-2311,463— $011,463SEC↗
Martin Patricia A.Director D To issuer deriv2026-03-192026-03-2310,362— $00SEC↗
Martin Patricia A.Director D To issuer deriv2026-03-192026-03-2324,999— $00SEC↗
Martin Patricia A.Director A Award deriv2026-03-192026-03-2324,999— $024,999SEC↗
Martin Patricia A.Director A Award deriv2026-03-192026-03-2310,362— $010,362SEC↗
Martin Patricia A.Director D To issuer deriv2026-03-192026-03-2323,742— $00SEC↗
Martin Patricia A.Director A Award deriv2026-03-192026-03-2323,742— $023,742SEC↗
Aziz KabeerDirector A Award deriv2026-03-192026-03-2323,742— $023,742SEC↗
Aziz KabeerDirector D To issuer deriv2026-03-192026-03-2323,742— $00SEC↗
Aziz KabeerDirector D To issuer deriv2026-03-192026-03-2320,724— $00SEC↗
Aziz KabeerDirector A Award deriv2026-03-192026-03-2320,724— $020,724SEC↗
Marks Gilbert LynnDirector D To issuer deriv2026-03-192026-03-2310,362— $00SEC↗
Marks Gilbert LynnDirector A Award deriv2026-03-192026-03-2323,742— $023,742SEC↗
Marks Gilbert LynnDirector D To issuer deriv2026-03-192026-03-2323,742— $00SEC↗
Marks Gilbert LynnDirector A Award deriv2026-03-192026-03-2310,362— $010,362SEC↗
Marks Gilbert LynnDirector A Award deriv2026-03-192026-03-2310,665— $010,665SEC↗
Marks Gilbert LynnDirector D To issuer deriv2026-03-192026-03-2310,665— $00SEC↗
Chanda SanjayChief Development Officer A Award deriv2026-03-192026-03-2366,000— $066,000SEC↗
Chanda SanjayChief Development Officer D To issuer deriv2026-03-192026-03-2341,665— $00SEC↗
Chanda SanjayChief Development Officer A Award deriv2026-03-192026-03-2341,665— $041,665SEC↗
Chanda SanjayChief Development Officer D To issuer deriv2026-03-192026-03-2357,950— $00SEC↗
Chanda SanjayChief Development Officer A Award deriv2026-03-192026-03-2357,950— $057,950SEC↗
Chanda SanjayChief Development Officer D To issuer deriv2026-03-192026-03-2366,000— $00SEC↗
Day LucyChief Financial Officer D To issuer deriv2026-03-192026-03-2382,300— $00SEC↗
Day LucyChief Financial Officer A Award deriv2026-03-192026-03-2373,665— $073,665SEC↗
Day LucyChief Financial Officer D To issuer deriv2026-03-192026-03-2373,665— $00SEC↗
Day LucyChief Financial Officer A Award deriv2026-03-192026-03-2366,000— $066,000SEC↗
Day LucyChief Financial Officer D To issuer deriv2026-03-192026-03-2366,000— $00SEC↗
Day LucyChief Financial Officer A Award deriv2026-03-192026-03-2382,300— $082,300SEC↗
Williams Sarah JoannePrincipal Accounting Officer S Sale2026-03-032026-03-05327$1.06 $34766,848SEC↗
Zakrzewski Joseph SDirector A Award deriv2026-02-202026-02-2320,400— $020,400SEC↗
FitzPatrick Margaret MDirector A Award deriv2026-02-202026-02-2320,400— $020,400SEC↗
Aziz KabeerDirector A Award deriv2026-02-202026-02-2320,400— $020,400SEC↗
Spigelman Melvin KDirector A Award deriv2026-02-202026-02-2320,400— $020,400SEC↗
Martin Patricia A.Director A Award deriv2026-02-202026-02-2320,400— $020,400SEC↗
Wong StephanieDirector A Award deriv2026-02-202026-02-2320,400— $020,400SEC↗
Readnour Robin ShaneDirector A Award deriv2026-02-202026-02-2320,400— $020,400SEC↗
Marks Gilbert LynnDirector A Award deriv2026-02-202026-02-2320,400— $020,400SEC↗
Chanda SanjayChief Development Officer A Award deriv2026-02-202026-02-2377,000— $077,000SEC↗
Easom EricChief Executive Officer A Award deriv2026-02-202026-02-23224,500— $0224,500SEC↗
Day LucyChief Financial Officer A Award deriv2026-02-202026-02-2377,000— $077,000SEC↗
Eizen Joshua MSee Remarks A Award deriv2026-02-202026-02-23100,000— $0100,000SEC↗
Chanda SanjayChief Development Officer A Award2026-02-202026-02-2338,000— $0118,823SEC↗
Easom EricChief Executive Officer A Award2026-02-202026-02-23112,250— $0368,630SEC↗
Williams Sarah JoannePrincipal Accounting Officer A Award2026-02-202026-02-2348,375— $067,175SEC↗
Day LucyChief Financial Officer A Award2026-02-202026-02-2338,000— $0118,363SEC↗
Eizen Joshua MSee Remarks A Award2026-02-202026-02-2350,000— $0207,499SEC↗
Marks Gilbert LynnDirector A Award2026-01-122026-01-1411,560— $075,309SEC↗
Martin Patricia A.Director A Award2026-01-122026-01-143,650— $016,905SEC↗
Aziz KabeerDirector A Award2026-01-122026-01-1411,560— $052,479SEC↗
Eizen Joshua MSee Remarks S Sale2026-01-062026-01-076,931$1.01 $7.0K152,499SEC↗
Chanda SanjayChief Development Officer S Sale2026-01-062026-01-075,956$1.01 $6.0K75,823SEC↗
Prior Stephen DavidChief Strategy Officer S Sale2026-01-062026-01-072,858$1.01 $2.9K59,086SEC↗
Day LucyChief Financial Officer S Sale2026-01-062026-01-075,512$1.01 $5.6K75,363SEC↗
Eizen Joshua MSee Remarks S Sale2026-01-052026-01-0717,923$1.00 $17.9K159,430SEC↗
Chanda SanjayChief Development Officer S Sale2026-01-052026-01-073,295$1.00 $3.3K81,779SEC↗
Prior Stephen DavidChief Strategy Officer S Sale2026-01-052026-01-073,604$1.00 $3.6K61,944SEC↗
Day LucyChief Financial Officer S Sale2026-01-052026-01-073,295$1.00 $3.3K80,875SEC↗
Prior Stephen DavidChief Strategy Officer S Sale2025-11-042025-11-06765$1.14 $87265,548SEC↗
Eizen Joshua MSee Remarks S Sale2025-11-042025-11-062,819$1.14 $3.2K177,353SEC↗
Martin Patricia A.Director A Award2025-10-102025-10-143,274— $013,255SEC↗
Aziz KabeerDirector A Award2025-10-102025-10-1410,367— $040,919SEC↗
Marks Gilbert LynnDirector A Award2025-10-102025-10-1410,367— $063,749SEC↗
Martin Patricia A.Director A Award2025-07-102025-07-113,750— $09,981SEC↗
Marks Gilbert LynnDirector A Award2025-07-102025-07-1111,875— $053,382SEC↗
Aziz KabeerDirector A Award2025-07-102025-07-1111,875— $030,552SEC↗
Easom EricChief Executive Officer P Buy2025-06-022025-06-0310,000$1.07 $10.7K256,380SEC↗
Leonard Braden Michael10% Owner S Sale2025-05-302025-05-30425,000$1.01 $429.3K3,224,432SEC↗
Leonard Braden Michael10% Owner S Sale2025-05-302025-05-307,000$1.03 $7.2K3,217,432SEC↗
FitzPatrick Margaret MDirector P Buy2025-05-282025-05-298,610$1.18 $10.2K8,610SEC↗
Leonard Braden Michael10% Owner S Sale2025-05-282025-05-302,000,000$1.16 $2.32M3,749,432SEC↗
Leonard Braden Michael10% Owner S Sale2025-05-282025-05-30100,000$1.16 $116.0K3,649,432SEC↗
Leonard Braden Michael10% Owner S Sale2025-05-282025-06-16200,000$1.09 $218.0K3,017,432SEC↗
Aziz KabeerDirector A Award deriv2025-05-222025-05-2319,111— $019,111SEC↗
Marks Gilbert LynnDirector A Award deriv2025-05-222025-05-2319,111— $019,111SEC↗
Wong StephanieDirector A Award deriv2025-05-222025-05-2319,111— $019,111SEC↗
Spigelman Melvin KDirector A Award deriv2025-05-222025-05-2319,111— $019,111SEC↗
Zakrzewski Joseph SDirector A Award deriv2025-05-222025-05-2319,111— $019,111SEC↗
FitzPatrick Margaret MDirector A Award deriv2025-05-222025-05-2319,111— $019,111SEC↗
Martin Patricia A.Director A Award deriv2025-05-222025-05-2319,111— $019,111SEC↗
Readnour Robin ShaneDirector A Award deriv2025-05-222025-05-2319,111— $019,111SEC↗
Marks Gilbert LynnDirector A Award2025-04-102025-04-119,705— $041,507SEC↗
Martin Patricia A.Director A Award2025-04-102025-04-113,065— $06,231SEC↗
Aziz KabeerDirector A Award2025-04-102025-04-119,705— $018,677SEC↗
Zakrzewski Joseph SDirector A Award2025-04-102025-04-1110,523— $0145,538SEC↗
Prior Stephen DavidChief Strategy Officer A Award deriv2025-02-262025-02-2856,000— $056,000SEC↗
Easom EricChief Executive Officer A Award deriv2025-02-262025-02-28290,500— $0290,500SEC↗
Eizen Joshua MSee Remarks A Award deriv2025-02-262025-02-28117,000— $0117,000SEC↗
Day LucyChief Financial Officer A Award deriv2025-02-262025-02-2893,000— $093,000SEC↗
Chanda SanjayChief Development Officer A Award deriv2025-02-262025-02-28100,500— $0100,500SEC↗
Prior Stephen DavidChief Strategy Officer A Award2025-02-262025-02-2828,000— $061,313SEC↗
Easom EricChief Executive Officer A Award2025-02-262025-02-28145,250— $0246,380SEC↗
Eizen Joshua MSee Remarks A Award2025-02-262025-02-2858,500— $0175,172SEC↗
Day LucyChief Financial Officer A Award2025-02-262025-02-2846,500— $079,170SEC↗
Chanda SanjayChief Development Officer A Award2025-02-262025-02-2850,250— $080,074SEC↗
Eizen Joshua MSee Remarks S Sale2025-01-032025-01-079,663$1.34 $12.9K116,672SEC↗
Prior Stephen DavidChief Strategy Officer S Sale2025-01-032025-01-072,029$1.34 $2.7K33,313SEC↗
Chanda SanjayChief Development Officer S Sale2025-01-032025-01-072,957$1.34 $4.0K29,824SEC↗
Day LucyChief Financial Officer S Sale2025-01-032025-01-072,957$1.34 $4.0K32,670SEC↗
Readnour Robin ShaneDirector A Award2024-12-192024-12-239,077— $09,077SEC↗
Zakrzewski Joseph SDirector A Award2024-12-192024-12-239,816— $0135,015SEC↗
Marks Gilbert LynnDirector A Award2024-12-192024-12-238,972— $031,802SEC↗
Aziz KabeerDirector A Award2024-12-192024-12-238,972— $08,972SEC↗
Martin Patricia A.Director A Award2024-12-192024-12-233,166— $03,166SEC↗
Readnour Robin ShaneDirector P Buy2024-12-102024-12-105,000$1.49 $7.5K582,288SEC↗
Readnour Robin ShaneDirector P Buy2024-12-102024-12-105,000$1.49 $7.5K652,573SEC↗
Readnour Robin ShaneDirector P Buy2024-12-092024-12-1012,289$1.43 $17.6K577,288SEC↗
Readnour Robin ShaneDirector P Buy2024-12-092024-12-1018,483$1.43 $26.4K647,573SEC↗
Readnour Robin ShaneDirector P Buy2024-12-062024-12-1012,711$1.45 $18.4K564,999SEC↗
Readnour Robin ShaneDirector P Buy2024-12-062024-12-106,517$1.45 $9.4K629,090SEC↗
Zakrzewski Joseph SDirector P Buy2024-11-272024-11-272,000$1.40 $2.8K125,199SEC↗
Readnour Robin ShaneDirector P Buy2024-11-272024-11-2725,000$1.42 $35.5K552,288SEC↗
Readnour Robin ShaneDirector P Buy2024-11-272024-11-2725,000$1.42 $35.5K622,573SEC↗
Readnour Robin ShaneDirector P Buy2024-11-262024-11-2712,500$1.39 $17.4K527,288SEC↗
Readnour Robin ShaneDirector P Buy2024-11-262024-11-2712,500$1.39 $17.4K597,573SEC↗
Readnour Robin ShaneDirector P Buy2024-11-202024-11-2125,000$1.16 $29.0K585,073SEC↗
Readnour Robin ShaneDirector P Buy2024-11-202024-11-2125,000$1.15 $28.7K514,788SEC↗
Zakrzewski Joseph SDirector P Buy2024-11-192024-11-205,000$1.01 $5.0K123,199SEC↗
Readnour Robin ShaneDirector P Buy2024-11-192024-11-2175,000$1.03 $77.3K560,073SEC↗
Readnour Robin ShaneDirector P Buy2024-11-192024-11-2175,000$1.04 $78.0K489,788SEC↗
Easom EricChief Executive Officer P Buy2024-11-182024-11-1850,000$1.00 $50.0K1,065,766SEC↗
Zakrzewski Joseph SDirector P Buy2024-11-182024-11-2020,000$1.00 $20.0K118,199SEC↗
Eizen Joshua MSee Remarks A Award deriv2024-11-042024-11-0563,000— $063,000SEC↗
Prior Stephen DavidChief Strategy Officer A Award deriv2024-11-042024-11-0520,250— $020,250SEC↗
Eizen Joshua MSee Remarks A Award2024-11-042024-11-0531,500— $0126,335SEC↗
Prior Stephen DavidChief Strategy Officer A Award2024-11-042024-11-0510,125— $035,342SEC↗
Leonard Braden Michael10% Owner P Buy2024-08-142024-08-141,500,000$1.04 $1.56M5,749,432SEC↗
RA Capital Healthcare Fund LP10% Owner S Sale2024-08-092024-08-133,410,335$1.08 $3.68M1,725,348SEC↗
RA Capital Healthcare Fund LP10% Owner S Sale2024-08-092024-08-13114,759$1.08 $123.9K300,853SEC↗
Eizen Joshua MChief Legal Officer A Award2024-07-102024-07-1260,000— $094,833SEC↗
Wong StephanieDirector A Award deriv2024-06-192024-06-2164,503— $064,503SEC↗
Martin Patricia A.Director A Award deriv2024-06-192024-06-2164,503— $064,503SEC↗
Spigelman Melvin KDirector A Award deriv2024-06-192024-06-2164,503— $064,503SEC↗
Zakrzewski Joseph SDirector A Award deriv2024-06-192024-06-2164,503— $064,503SEC↗
Aziz KabeerDirector A Award deriv2024-06-192024-06-2164,503— $064,503SEC↗
FitzPatrick Margaret MDirector A Award deriv2024-06-192024-06-2164,503— $064,503SEC↗
Marks Gilbert LynnDirector A Award deriv2024-06-192024-06-2164,503— $064,503SEC↗
Readnour Robin ShaneDirector A Award deriv2024-06-192024-06-2164,503— $064,503SEC↗
Easom EricChief Executive Officer A Award deriv2024-03-152024-03-18198,000— $0198,000SEC↗
Eckburg PaulChief Medical Officer A Award deriv2024-03-152024-03-1860,000— $060,000SEC↗
Chanda SanjayChief Development Officer A Award deriv2024-03-152024-03-1855,000— $055,000SEC↗
Krause Kevin MichaelChief Strategy Officer A Award deriv2024-03-152024-03-1860,000— $060,000SEC↗
Eizen Joshua MChief Legal Officer A Award deriv2024-03-152024-03-1860,000— $060,000SEC↗
Day LucyChief Financial Officer A Award deriv2024-03-152024-03-1855,000— $055,000SEC↗
Easom EricChief Executive Officer A Award2024-03-152024-03-1899,000— $0101,130SEC↗
Eckburg PaulChief Medical Officer A Award2024-03-152024-03-1830,000— $051,416SEC↗
Chanda SanjayChief Development Officer A Award2024-03-152024-03-1827,500— $028,235SEC↗
Krause Kevin MichaelChief Strategy Officer A Award2024-03-152024-03-1830,000— $031,914SEC↗
Eizen Joshua MChief Legal Officer A Award2024-03-152024-03-1830,000— $032,447SEC↗
Day LucyChief Financial Officer A Award2024-03-152024-03-1827,500— $030,627SEC↗
Easom EricChief Executive Officer A Award2024-03-152024-03-2999,000— $0101,130SEC↗
Chanda SanjayChief Development Officer A Award2024-03-152024-03-2927,500— $028,235SEC↗
Krause Kevin MichaelChief Strategy Officer A Award2024-03-152024-03-2930,000— $031,914SEC↗
Eizen Joshua MChief Legal Officer A Award2024-03-152024-03-2930,000— $032,447SEC↗
Day LucyChief Financial Officer A Award2024-03-152024-03-2927,500— $030,627SEC↗
Eckburg PaulChief Medical Officer A Award2024-03-152024-03-2930,000— $051,416SEC↗
Zakrzewski Joseph SDirector S Sale2024-01-182024-01-19100,000$19.11 $1.91M405,880SEC↗
Adjuvant Capital Management, L10% Owner S Sale2024-01-162024-01-1884,093$19.65 $1.65M1,995,958SEC↗
Adjuvant Capital Management, L10% Owner S Sale2024-01-162024-01-1815,907$19.65 $312.6K377,542SEC↗
Aziz KabeerDirector S Sale2024-01-162024-01-1815,907$19.65 $312.6K377,542SEC↗
Aziz KabeerDirector S Sale2024-01-162024-01-1884,093$19.65 $1.65M1,995,958SEC↗
Readnour Robin ShaneDirector S Sale2024-01-122024-01-17719$21.91 $15.8K485,073SEC↗
Readnour Robin ShaneDirector S Sale2024-01-122024-01-17706$21.92 $15.5K414,788SEC↗
Readnour Robin ShaneDirector S Sale2024-01-102024-01-121,800$21.92 $39.5K485,792SEC↗
Readnour Robin ShaneDirector S Sale2024-01-102024-01-121,869$21.93 $41.0K415,494SEC↗
Krause Kevin MichaelChief Strategy Officer M Exercise deriv2024-01-092024-01-115,000— $026,832SEC↗
Krause Kevin MichaelChief Strategy Officer M Exercise deriv2024-01-092024-01-112,417— $049,868SEC↗
Krause Kevin MichaelChief Strategy Officer M Exercise2024-01-092024-01-115,000$6.60 $33.0K9,331SEC↗
Krause Kevin MichaelChief Strategy Officer S Sale2024-01-092024-01-117,417$20.14 $149.4K1,914SEC↗
Krause Kevin MichaelChief Strategy Officer M Exercise2024-01-092024-01-112,417$0.42 $1.0K4,331SEC↗
Krause Kevin MichaelChief Strategy Officer M Exercise deriv2024-01-022024-01-042,583— $052,285SEC↗
Easom EricChief Executive Officer S Sale2024-01-022024-01-042,777$20.09 $55.8K2,130SEC↗
Krause Kevin MichaelChief Strategy Officer S Sale2024-01-022024-01-042,583$20.12 $52.0K1,914SEC↗
Krause Kevin MichaelChief Strategy Officer M Exercise2024-01-022024-01-042,583$0.42 $1.1K4,497SEC↗
Aziz KabeerDirector, 10% Owner S Sale2023-11-142023-11-161,522$16.15 $24.6K2,080,051SEC↗
Aziz KabeerDirector, 10% Owner S Sale2023-11-142023-11-16288$16.15 $4.7K393,449SEC↗
Adjuvant Capital Management, L10% Owner S Sale2023-11-142023-11-161,522$16.15 $24.6K2,080,051SEC↗
Adjuvant Capital Management, L10% Owner S Sale2023-11-142023-11-16288$16.15 $4.7K393,449SEC↗
Adjuvant Global Health Technol10% Owner S Sale2023-10-022023-10-034,770$16.07 $76.7K2,081,573SEC↗
Adjuvant Global Health Technol10% Owner S Sale2023-10-022023-10-03902$16.07 $14.5K393,737SEC↗
Aziz KabeerDirector, 10% Owner S Sale2023-10-022023-10-034,770$16.07 $76.7K2,081,573SEC↗
Aziz KabeerDirector, 10% Owner S Sale2023-10-022023-10-03902$16.07 $14.5K393,737SEC↗
Adjuvant Global Health Technol10% Owner S Sale2023-09-292023-10-0383,337$16.28 $1.36M2,086,343SEC↗
Adjuvant Global Health Technol10% Owner S Sale2023-09-292023-10-0315,764$16.28 $256.6K394,639SEC↗
Aziz KabeerDirector, 10% Owner S Sale2023-09-292023-10-0383,337$16.28 $1.36M2,086,343SEC↗
Aziz KabeerDirector, 10% Owner S Sale2023-09-292023-10-0315,764$16.28 $256.6K394,639SEC↗
Aziz KabeerDirector, 10% Owner S Sale2023-09-282023-09-291,356$16.11 $21.8K410,403SEC↗
Aziz KabeerDirector, 10% Owner S Sale2023-09-282023-09-297,160$16.11 $115.3K2,169,680SEC↗
Adjuvant Global Health Technol10% Owner S Sale2023-09-282023-09-291,356$16.11 $21.8K410,403SEC↗
Adjuvant Global Health Technol10% Owner S Sale2023-09-282023-09-297,160$16.11 $115.3K2,169,680SEC↗
Aziz KabeerDirector, 10% Owner S Sale2023-09-272023-09-29707$16.07 $11.4K2,176,840SEC↗
Aziz KabeerDirector, 10% Owner S Sale2023-09-272023-09-29134$16.07 $2.2K411,759SEC↗
Adjuvant Global Health Technol10% Owner S Sale2023-09-272023-09-29707$16.07 $11.4K2,176,840SEC↗
Adjuvant Global Health Technol10% Owner S Sale2023-09-272023-09-29134$16.07 $2.2K411,759SEC↗
Adjuvant Global Health Technol10% Owner S Sale2023-09-132023-09-1564$16.00 $1.0K411,893SEC↗
Adjuvant Global Health Technol10% Owner S Sale2023-09-132023-09-15336$16.00 $5.4K2,177,547SEC↗
Aziz KabeerDirector, 10% Owner S Sale2023-09-132023-09-15336$16.00 $5.4K2,177,547SEC↗
Aziz KabeerDirector, 10% Owner S Sale2023-09-132023-09-1564$16.00 $1.0K411,893SEC↗
Aziz KabeerDirector, 10% Owner S Sale2023-09-072023-09-082,841$16.05 $45.6K2,177,883SEC↗
Aziz KabeerDirector, 10% Owner S Sale2023-09-072023-09-08537$16.05 $8.6K411,957SEC↗
Adjuvant Global Health Technol10% Owner S Sale2023-09-072023-09-082,841$16.05 $45.6K2,177,883SEC↗
Adjuvant Global Health Technol10% Owner S Sale2023-09-072023-09-08537$16.05 $8.6K411,957SEC↗
Aziz KabeerDirector, 10% Owner S Sale2023-09-062023-09-08598$16.02 $9.6K412,494SEC↗
Aziz KabeerDirector, 10% Owner S Sale2023-09-062023-09-083,164$16.02 $50.7K2,180,724SEC↗
Adjuvant Global Health Technol10% Owner S Sale2023-09-062023-09-08598$16.02 $9.6K412,494SEC↗
Adjuvant Global Health Technol10% Owner S Sale2023-09-062023-09-083,164$16.02 $50.7K2,180,724SEC↗
Aziz KabeerDirector, 10% Owner S Sale2023-08-232023-08-2564$16.00 $1.0K413,092SEC↗
Aziz KabeerDirector, 10% Owner S Sale2023-08-232023-08-25336$16.00 $5.4K2,183,888SEC↗
Adjuvant Capital GP, L.P.10% Owner S Sale2023-08-232023-08-2564$16.00 $1.0K413,092SEC↗
Adjuvant Capital GP, L.P.10% Owner S Sale2023-08-232023-08-25336$16.00 $5.4K2,183,888SEC↗
RA Capital Nexus Fund II, L.P.10% Owner P Buy2023-08-182023-08-221,777,778$9.00 $16.00M5,135,683SEC↗
Readnour Robin ShaneDirector A Award deriv2023-06-072023-06-0923,742— $023,742SEC↗
Spigelman Melvin KDirector A Award deriv2023-06-072023-06-0923,742— $023,742SEC↗
Martin Patricia A.Director A Award deriv2023-06-072023-06-0923,742— $023,742SEC↗
Marks Gilbert LynnDirector A Award deriv2023-06-072023-06-0923,742— $023,742SEC↗
Wong StephanieDirector A Award deriv2023-06-072023-06-0923,742— $023,742SEC↗
FitzPatrick Margaret MDirector A Award deriv2023-06-072023-06-0923,742— $023,742SEC↗
Zakrzewski Joseph SDirector A Award deriv2023-06-072023-06-0923,742— $023,742SEC↗
Aziz KabeerDirector, 10% Owner A Award deriv2023-06-072023-06-0923,742— $023,742SEC↗
Easom EricChief Executive Officer P Buy2023-05-152023-05-1510,000$5.38 $53.8K1,015,766SEC↗
Easom EricChief Executive Officer A Award deriv2023-02-232023-02-24267,650— $0267,650SEC↗
Krause Kevin MichaelChief Strategy Officer A Award deriv2023-02-152023-02-1762,200— $062,200SEC↗
Nazak Michael AdrianChief Accounting Officer A Award deriv2023-02-152023-02-1716,600— $016,600SEC↗
Eizen Joshua MChief Legal Officer A Award deriv2023-02-152023-02-1750,150— $050,150SEC↗
Eckburg PaulChief Medical Officer A Award deriv2023-02-152023-02-1770,950— $070,950SEC↗
Chanda SanjayChief Development Officer A Award deriv2023-02-152023-02-1757,950— $057,950SEC↗